A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Abroad (travel likely)RecruitingPHASE2

Conditions

Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Scot Niglio, MD, MS) · 646-888-4717
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Scot Niglio, MD, MS) · 646-888-4867
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Scot Niglio, MD, MS) · 646-888-4867
  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities), Commack, New York, United States

    Contact: Study coordinator (Scot Niglio, MD, MS) · 646-888-4867
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Scot Niglio, MD, MS) · 646-888-4867
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Scot Niglio, MD, MS) · 646-888-4867
    Contact: Study coordinator (Jonathan Rosenberg, MD) · 646-888-4741
  • University of Rochester Medical Center (Data Collection Only), Rochester, New York, United States

    Contact: Study coordinator (Brendan Guercio, MD) · 585-275-5823
  • Memorial Sloan Kettering Nassau (Limited protocol activities), Uniondale, New York, United States

    Contact: Study coordinator (Scot Niglio, MD, MS) · 646-888-4867
Study leads
  • Scot Niglio, MD, MS

    Principal Investigator

    Memorial Sloan Kettering Cancer Center